Compared to the HBV-CLD cohort, the HBV-ACLF cohort had higher rates of liver cirrhosis, alcohol consumption, lower albumin, lower rates of family history of HCC, and higher levels of TBiL, ALT, and AST. The gene discussed is ALB; the disease is hepatocellular carcinoma.